NUVL Valuation

Nuvalent Inc

Add to Watchlist

Advanced Chart

93.020

-6.3(-6.343%)1D

NUVL Relative Valuation

NUVL's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, NUVL is overvalued; if below, it's undervalued.

Historical Valuation

Nuvalent Inc (NUVL) is now in the Fair zone, suggesting that its current forward PS ratio of 99.32 is considered Fairly compared with the five-year average of -16.48. The fair price of Nuvalent Inc (NUVL) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：93.02

Fair

-17.70

Trailing

Forward

-14.60

EV/EBITDA

Nuvalent Inc. (NUVL) has a current EV/EBITDA of -14.60. The 5-year average EV/EBITDA is -12.90. The thresholds are as follows: Strongly Undervalued below -24.42, Undervalued between -24.42 and -18.66, Fairly Valued between -7.14 and -18.66, Overvalued between -7.14 and -1.38, and Strongly Overvalued above -1.38. The current Forward EV/EBITDA of -14.60 falls within the Historic Trend Line -Fairly Valued range.

-15.10

EV/EBIT

Nuvalent Inc. (NUVL) has a current EV/EBIT of -15.10. The 5-year average EV/EBIT is -12.66. The thresholds are as follows: Strongly Undervalued below -24.20, Undervalued between -24.20 and -18.43, Fairly Valued between -6.88 and -18.43, Overvalued between -6.88 and -1.11, and Strongly Overvalued above -1.11. The current Forward EV/EBIT of -15.10 falls within the Historic Trend Line -Fairly Valued range.

99.32

Nuvalent Inc. (NUVL) has a current PS of 99.32. The 5-year average PS is 113.60. The thresholds are as follows: Strongly Undervalued below -788.69, Undervalued between -788.69 and -337.54, Fairly Valued between 564.75 and -337.54, Overvalued between 564.75 and 1015.90, and Strongly Overvalued above 1015.90. The current Forward PS of 99.32 falls within the Historic Trend Line -Fairly Valued range.

-22.95

P/OCF

Nuvalent Inc. (NUVL) has a current P/OCF of -22.95. The 5-year average P/OCF is -19.19. The thresholds are as follows: Strongly Undervalued below -34.99, Undervalued between -34.99 and -27.09, Fairly Valued between -11.29 and -27.09, Overvalued between -11.29 and -3.39, and Strongly Overvalued above -3.39. The current Forward P/OCF of -22.95 falls within the Historic Trend Line -Fairly Valued range.

-25.29

P/FCF

Nuvalent Inc. (NUVL) has a current P/FCF of -25.29. The 5-year average P/FCF is -10.50. The thresholds are as follows: Strongly Undervalued below -39.16, Undervalued between -39.16 and -24.83, Fairly Valued between 3.83 and -24.83, Overvalued between 3.83 and 18.16, and Strongly Overvalued above 18.16. The current Forward P/FCF of -25.29 falls within the Undervalued range.

Nuvalent Inc (NUVL) has a current Price-to-Book (P/B) ratio of 0.00. Compared to its 3-year average P/B ratio of 6.31 , the current P/B ratio is approximately -100.00% higher. Relative to its 5-year average P/B ratio of 5.09, the current P/B ratio is about -100.00% higher. Nuvalent Inc (NUVL) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -3.07%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -3.84% , the current FCF yield is about -100.00% lower.

0.00

P/B

Median3y

6.31

Median5y

5.09

0.00

FCF Yield

Median3y

-3.07

Median5y

-3.84

Competitors Valuation Multiple

The average P/S ratio for NUVL's competitors is 69.75, providing a benchmark for relative valuation. Nuvalent Inc Corp (NUVL) exhibits a P/S ratio of 99.32, which is 42.39% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Rhythm Pharmaceuticals Inc

Corcept Therapeutics Inc

Performance Decomposition

Market capitalization of NUVL increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of NUVL in the past 1 year is driven by Unknown.